Posted by Michael Wonder on 25 Oct 2022
PHARMAC considers funding meningococcal B vaccine to be part of childhood immunisations
26 October 2022 - PHARMAC today has announced a consultation on widening access to the meningococcal B vaccine (branded as Bexsero), which would give thousands of young people and infants protection against meningococcal B disease.
The proposal would allow for its inclusion in the childhood immunisation schedule.
